Beigene (ONC) Stock Price, News & Analysis

Company Overview

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.

Key Stats

• Today's Range: $219.38 to $226.08
• 50-Day Range: N/A
• 52-Week Range: $126.97 to $248.16
• Volume: 172,276 shs
• Average Volume: 325,750 shs
• Market Capitalization: $21.60 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ONC Stock Analysis - Frequently Asked Questions

How have ONC shares performed this year?

Beigene's stock was trading at $223.50 at the beginning of 2025. Since then, ONC shares have decreased by 1.3% and is now trading at $220.50.
View the best growth stocks for 2025 here.

How do I buy shares of Beigene?

Shares of ONC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 2/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ONC
• Previous Symbol: NASDAQ:ONC
• CUSIP: N/A
• CIK: 1651308
• Web: N/A
• Phone: 13459494123
• Fax: N/A
• Employees: 10,600
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($8.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-881,710,000.00
• Net Margins: -25.94%
• Pretax Margin: -24.07%
• Return on Equity: -25.12%
• Return on Assets: -14.95%

Debt

• Debt-to-Equity Ratio: 0.05
• Current Ratio: 1.93
• Quick Ratio: 1.72

Sales & Book Value

• Annual Sales: $2.46 billion
• Price / Sales: 8.76
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $37.10 per share
• Price / Book: 5.94

Miscellaneous

• Outstanding Shares: 97,720,000
• Free Float: 90,458,000
• Market Cap: $21.55 billion
• Optionable: N/A
• Beta: 0.63